Medicines Formulary

Medicines A–Z

C

Drug name	NICE TAs	Comments
Cosopt eye drops		Specialist ophthalmologist recommendation
Cosopt eye drops (preserv free)		Specialist ophthalmologist recommendation
Creon®		For use in swallowing difficulties or via nasogastric tube
Crisantaspase injection
Crizanlizumab (Adakveo®)	TA743 - Crizanlizumab for preventing sickle cell crises in sickle cell disease
Crizotinib	TA296 - Critzotinib for previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase fusion gene TA529 - Crizotinib for treating ROS1-positive advanced non-small-cell lung cancer
Crotamiton 10% cream
Crystacide® cream
Cyanocobalamin tablets
Cyclizine injection		For palliative care use

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.